Patent details

301063 Product Name: Andexanet alfa

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301063
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3078743
Status:
SPC granted but not yet in force
Application number:
301063
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1345
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/04/2019
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
09/09/2020
First Marketing Authorization date:
30/04/2019
Grant date:
23/06/2021
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
09/09/2020
SPC/SPC Extension Expiration Date:
25/09/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
27/05/2021
 
 

 

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, 02210, Boston, MA, United States of America (US)

Historical Applicant/holder

From:
27/05/2021
To:
27/05/2021

 

Name:
Portola Pharmaceuticals, LLC
Address:
270 East Grand Avenue, 94080, South San Francisco, California, United States of America (US)

From:
09/09/2020
To:
27/05/2021

 

Name:
Portola Pharmaceuticals, Inc.
Address:
270 East Grand Avenue Suite 22, SOUTH SAN FRANCISCO CALIFORNIA 94080, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
09/09/2020
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
CO
Journal edition number:
25/21
Publication date:
23/06/2021
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
CO
Journal edition number:
25/21
Publication date:
23/06/2021
Description:
Changes in the Netherlands Patent Register

4

Bulletin Heading:
SPC
Journal edition number:
38/20
Publication date:
16/09/2020
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202101080A
Date Registered:
27/05/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Portola Pharmaceuticals, LLC
Address:
270 East Grand Avenue, 94080, South San Francisco, California, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC202101080B
Date Registered:
27/05/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

Name:
Alexion Pharmaceuticals, Inc.
Address:
121 Seaport Boulevard, 02210, Boston, MA, United States of America (US)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
30/09/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
23/06/2021 Certificate Certificate 1 PDF /9/1/8/9/9/0800599819/docs/301063_2_spcmedcertificate20210623130607140.pdf
23/06/2021 Outgoing Correspondence Decision grant 1 PDF /9/1/8/9/9/0800599819/docs/301063_11_418992l504a.pdf
27/05/2021 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /9/1/8/9/9/0800599819/docs/301063_5_incomingcorrespondencepaper20210528102230217.pdf
04/03/2021 Outgoing Correspondence Letter to applicant 1 PDF /9/1/8/9/9/0800599819/docs/301063_12_398028l173.pdf
09/12/2020 Outgoing Correspondence Letter to applicant 1 PDF /9/1/8/9/9/0800599819/docs/301063_6_383299l173.pdf
08/12/2020 SPC Documents Accompanying letter SPC 1 PDF /9/1/8/9/9/0800599819/docs/301063_13_supplprotectioncertificate20201208112734179.pdf
10/09/2020 Outgoing Correspondence Letter to applicant 1 PDF /9/1/8/9/9/0800599819/docs/301063_14_365801l173.pdf
09/09/2020 SPC Documents Annex SPC 2 PDF /9/1/8/9/9/0800599819/docs/301063_0_supplprotectioncertificate20200909123432740.pdf
09/09/2020 Application Form First filed application form 2 PDF /9/1/8/9/9/0800599819/docs/301063_1_applicationform20200909122629938.pdf
09/09/2020 Publication Publication 1 PDF /9/1/8/9/9/0800599819/docs/301063_3_i1document20200909134401315.pdf
09/09/2020 SPC Documents Summary of the characteristics of the product 16 PDF /9/1/8/9/9/0800599819/docs/301063_4_supplprotectioncertificate20200909123432562.pdf
09/09/2020 SPC Documents Marketing Authorization SPC 4 PDF /9/1/8/9/9/0800599819/docs/301063_7_supplprotectioncertificate20200909123459417.pdf
09/09/2020 SPC Documents Annex SPC 3 PDF /9/1/8/9/9/0800599819/docs/301063_8_supplprotectioncertificate20200909123432628.pdf
09/09/2020 SPC Documents Annex SPC 13 PDF /9/1/8/9/9/0800599819/docs/301063_9_supplprotectioncertificate20200909123432692.pdf
09/09/2020 SPC Documents Accompanying letter SPC 3 PDF /9/1/8/9/9/0800599819/docs/301063_10_supplprotectioncertificate20200909123622731.pdf
09/09/2020 Front Page Front Page 1 PDF /9/1/8/9/9/0800599819/docs/301063_15_i1frontpage20200909134400808.pdf
09/09/2020 SPC Documents Annex SPC 15 PDF /9/1/8/9/9/0800599819/docs/301063_16_supplprotectioncertificate20200909123524355.pdf
09/09/2020 Outgoing Correspondence Confirmation receipt request 1 PDF /9/1/8/9/9/0800599819/docs/301063_17_365718l174.pdf